SLC11A2 and triple-negative breast carcinoma: These results indicate that although high expression of DMT1 is detected in primary tumors, DMT1 expression is downregulated once these cells reach the metastatic site and undergo metastatic growth being specifically associated with triple-negative breast cancer phenotype.